MiniMed's MiniMed Flex Insulin Pump Receives FDA Clearance

MiniMed (Nasdaq: MMED) has received FDA clearance for its MiniMed Flex™, a next-generation, discreet, smartphone-controlled insulin pump designed for daily use. The MiniMed Flex™ is half the size of the MiniMed® 780G pump and features a screenless design developed in collaboration with diabetes patients. It utilizes the advanced SmartGuard™ algorithm with Meal Detection™ technology, and will launch with the company's latest sensor portfolio, including the Simplera Sync™ and Instinct sensors from Abbott.